Renaud Capdeville
Impact in
- Hematology top 0.05%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 36
- Chronic Myeloid Leukemia Treatments 29
- Genetics 24
- Chronic Lymphocytic Leukemia Research 21
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- Brian Druker (9 shared papers)Charles L. Sawyers (6 shared papers)Moshe Talpaz (6 shared papers)Debra Resta (6 shared papers)J. Ford (6 shared papers)Elisabeth Buchdunger (3 shared papers)Hagop M. Kantarjian (4 shared papers)Bin Peng (8 shared papers)
- Journals
- Blood (4 papers)New England Journal of Medicine (4 papers)Clinical Cancer Research (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Seminars in Hematology (2 papers)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Renaud Capdeville
51 papers receiving 12.5k citations
Renaud Capdeville's Hit Papers
Peers
Comparison fields: 5 of 130
- Hematology 6.8k
- Genetics 5.0k
- Gastroenterology 1.6k
- Rheumatology 3.3k
- Oncology 2.8k
Countries citing papers authored by Renaud Capdeville
This map shows the geographic impact of Renaud Capdeville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Capdeville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Capdeville more than expected).
Fields of papers citing papers by Renaud Capdeville
This network shows the impact of papers produced by Renaud Capdeville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Capdeville. The network helps show where Renaud Capdeville may publish in the future.
Co-authors
The 25 scholars most cited alongside Renaud Capdeville, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Hit paper breakdown → | 2001 | 3811 |
| 2 | Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome Hit paper breakdown → | 2001 | 2070 |
| 3 | Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor Hit paper breakdown → | 2001 | 1525 |
| 4 | Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia Hit paper breakdown → | 2002 | 1517 |
| 5 | Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug Hit paper breakdown → | 2002 | 1067 |
| 6 | Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Hit paper breakdown → | 1998 | 724 |
| 7 | 2004 | 371 | |
| 8 | 2004 | 170 | |
| 9 | 2004 | 131 | |
| 10 | 2004 | 126 | |
| 11 | 2003 | 125 | |
| 12 | 2004 | 121 | |
| 13 | 2018 | 113 | |
| 14 | 2005 | 105 | |
| 15 | 2002 | 104 | |
| 16 | 1997 | 92 | |
| 17 | Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate. | 2002 | 85 |
| 18 | 1985 | 62 | |
| 19 | 2004 | 62 | |
| 20 | 2001 | 59 |
About Renaud Capdeville
Renaud Capdeville is a scholar working on Hematology, Genetics, Rheumatology, Oncology and Molecular Biology, having authored 52 papers that have together received 13.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (29 papers), Chronic Lymphocytic Leukemia Research (21 papers), Eosinophilic Disorders and Syndromes (16 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Mast cells and histamine (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Polyamine Metabolism and Applications (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (6.8k citations), Genetics (5.0k citations), Gastroenterology (1.6k citations), Rheumatology (3.3k citations) and Oncology (2.8k citations). Renaud Capdeville has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Brian Druker, Charles L. Sawyers, Moshe Talpaz, Debra Resta, J. Ford, Elisabeth Buchdunger, Hagop M. Kantarjian, Bin Peng, Sayuri Ohno-Jones and Nicholas Lydon. Their work appears in journals such as Blood, New England Journal of Medicine, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and Seminars in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.